¹û¶³´«Ã½app

Professor Oyelola Adegboye is JCU’s Public Health and Tropical Medicine Adjunct and a Menzies School of Health Research Associate Professor. He said the disease was endemic to Central and West Africa and it was believed that outbreaks in Africa (pre-2022) were a result of human contact with infected animals or their bodily fluids.

“Surveillance data between 2001 and 2015 showed children and adolescents aged 0–14 accounted for more than 70% of the cases, but the 2022 global outbreak showed it was occurring primarily in adults, with almost 97% males,” said Dr Adegboye.

He said monkeypox causes a wide range of symptoms, including fever, headache, muscle pain, swollen lymph nodes, and a distinctive rash.

“There is relatively low human-to-human transmissibility of the virus, with most people experiencing mild illness and recovering within a few weeks, but it can be severe in immunocompromised people.

“Mortality rates in severe cases range from 1% to 10%, depending on the outbreak setting, the specific virus family, and the quality of healthcare,” said Dr Adegboye.

He said while monkeypox is usually transmitted from animal-to-human and human-to-human in Africa, recent evidence suggests its primary mode of spread elsewhere is through unprotected sex, with a low chance of it also being spread through respiratory droplets.

“As of 18 April 2023, more than 87,000 cases and 120 deaths had been reported in 110 countries,” said Dr Adegboye.

He said while there is no specific cure for the virus, smallpox vaccines are available and have been shown to provide protection against the disease.

“Mass gatherings and the ease of international travel played a pivotal role in the spread of monkeypox.

“It was a relatively rare disease in a remote part of Africa for many years. But as urbanisation, forest loss, and land use patterns alter, exposure to and outbreaks of monkeypox and other obscure zoonotic diseases are going to increase. We absolutely cannot afford to be complacent about the risks we face.”